Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism GRIA2 modulators(glutamate ionotropic receptor AMPA type subunit 2 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Multiple Sclerosis | Preclinical | CA | 08 Dec 2023 |